- Patent Title: Modified peptides and their use for treating autoimmune diseases
-
Application No.: US14562350Application Date: 2014-12-05
-
Publication No.: US09657072B2Publication Date: 2017-05-23
- Inventor: Sylviane Muller , Jean-Paul Briand , Robert H. Zimmer
- Applicant: Centre National De La Rechereche Scientifique , Immupharma France SA
- Applicant Address: FR Paris FR Mulhouse
- Assignee: Centre National De La Recherche Scientifique,Immupharma France SA
- Current Assignee: Centre National De La Recherche Scientifique,Immupharma France SA
- Current Assignee Address: FR Paris FR Mulhouse
- Agency: Locke Lord LLP
- Agent Bryan D. Zerhusen
- Main IPC: C07K14/47
- IPC: C07K14/47 ; C07K7/08 ; A61K38/17 ; A61K38/00
Abstract:
The present invention relates to a peptide, or a salt thereof, comprising or consisting of the amino acid sequence IHMVYSKRSGKPRGYAFIEY, comprising one or more post-translational modifications.
Public/Granted literature
- US20150111835A1 MODIFIED PEPTIDES AND THEIR USE FOR TREATING AUTOIMMUNE DISEASES Public/Granted day:2015-04-23
Information query
